Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen & Michael A Heneghan. (2021) An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 22:11, pages 1475-1488.
Read now
Read now
Articles from other publishers (39)
. (2023) KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clinical and Molecular Hepatology 29:3, pages 542-592.
Crossref
Crossref
Ja Kyung Kim. (2023) Treatment of Autoimmune Hepatitis. The Korean Journal of Gastroenterology 81:2, pages 72-85.
Crossref
Crossref
玉兰 朱. (2023) Diagnosis and Treatment of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome. Advances in Clinical Medicine 13:03, pages 4678-4685.
Crossref
Crossref
Linda Skibsted Kornerup, Lisbet Grønbæk, Mikkel Breinholt Kjær & Henning Grønbæk. 2023. Comprehensive Guide to Hepatitis Advances. Comprehensive Guide to Hepatitis Advances
429
441
.
Sara Harsini & Nima Rezaei. 2023. Clinical Immunology. Clinical Immunology
123
244
.
Ignasi Olivas, Sergio Rodríguez-Tajes & Maria Carlota Londoño. (2022) Hepatitis autoinmune: retos y novedades. Medicina Clínica 159:6, pages 289-298.
Crossref
Crossref
Ignasi Olivas, Sergio Rodriguez-Tajes & Maria Carlota Londoño. (2022) Autoimmune hepatitis: Challenges and novelties. Medicina Clínica (English Edition) 159:6, pages 289-298.
Crossref
Crossref
Y. Y. Chung & Michael A. Heneghan. (2022) Autoimmune hepatitis in pregnancy: Pearls and pitfalls. Hepatology 76:2, pages 502-517.
Crossref
Crossref
Kehui Zhang, Jiacheng Li, Zhe Shi, Yingying Zhu, Jing Yang, Xiaolin Liu, Renye Que, Liubing Lin, Yirong Chen & Yong Li. (2022) Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway. Frontiers in Immunology 13.
Crossref
Crossref
Giulia Jannone, Isabelle Scheers, Françoise Smets, Xavier Stephenne & Etienne M Sokal. (2022) Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis. JPGN Reports 3:3, pages e227.
Crossref
Crossref
Nedim Hadžić & Marianne Samyn. 2022. Liver Disease in Adolescence. Liver Disease in Adolescence
129
141
.
Diego Vergani, Benedetta Terziroli Beretta-Piccoli & Giorgina Mieli-Vergani. (2021) A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 53:11, pages 1381-1393.
Crossref
Crossref
Rodrigo Liberal, Ynto S de Boer & Michael A Heneghan. (2021) Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 6:4, pages 315-326.
Crossref
Crossref
Ansgar W. Lohse, Marcial Sebode, Marianne H. Jørgensen, Henriette Ytting, Tom H. Karlsen, Deirdre Kelly, Michael P. Manns & Mette Vesterhus. (2020) Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology 73:6, pages 1496-1506.
Crossref
Crossref
Stephan Klöß, Susann Dehmel, Armin Braun, Michael J. Parnham, Ulrike Köhl & Susanne Schiffmann. (2020) From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment. Frontiers in Immunology 11.
Crossref
Crossref
Diego Vergani, Ian R. Mackay & Giorgina Mieli-Vergani. 2020. The Autoimmune Diseases. The Autoimmune Diseases
1117
1147
.
Paul A. Schmeltzer. 2020. Diagnosis and Management of Autoimmune Hepatitis. Diagnosis and Management of Autoimmune Hepatitis
93
108
.
Marco Sciveres, Silvia Nastasio & Giuseppe Maggiore. (2019) Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis. Frontiers in Pediatrics 7.
Crossref
Crossref
Marilena Durazzo, Giulia Lupi, Michela Scandella, Arianna Ferro & Gabriella Gruden. (2019) Autoimmune hepatitis treatment in the elderly: A systematic review. World Journal of Gastroenterology 25:22, pages 2809-2818.
Crossref
Crossref
Iliana Doycheva, Kymberly D. Watt & Aliya F. Gulamhusein. (2019) Autoimmune hepatitis: Current and future therapeutic options. Liver International 39:6, pages 1002-1013.
Crossref
Crossref
Carolin F. Manthey, Marcial Sebode, Helen Hayward-Koennecke, Andreas Lutterotti & Samuel Huber. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology
751
775
.
Richard Taubert, Katharina Luise Hupa-Breier, Elmar Jaeckel & Michael P. Manns. (2018) Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 95, pages 34-46.
Crossref
Crossref
M. V. Matsievich, A. O. Bueverov & M. Yu. Petrachenkova. (2018) Alternative treatment regimens in autoimmune hepatitis: how justified is their choice?. Almanac of Clinical Medicine 46:5, pages 504-513.
Crossref
Crossref
Keaton R. Jones & Craig S. Lammert. (2018) Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 17:3, pages 166-174.
Crossref
Crossref
Cumali Efe, Haider Al Taii, Henriette Ytting, Niklas Aehling, Rahima A. Bhanji, Hannes Hagström, Tugrul Purnak, Luigi Muratori, Mårten Werner, Paolo Muratori, Daniel Klintman, Thomas D. Schiano, Aldo J. Montano-Loza, Thomas Berg, Fin Stolze Larsen, Naim Alkhouri, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida & Staffan Wahlin. (2018) Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 63:5, pages 1348-1354.
Crossref
Crossref
Feng‑Bin Lu, En‑De Hu Hu, Lan‑Man Xu, Yi‑Bing Hu, Lu Chen, Jin‑Lu Wu, Hui Li, Da‑Zhi Chen & Yong‑Ping Chen. (2018) Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta‑analysis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Timur Liwinski & Christoph Schramm. (2017) Autoimmune hepatitis — update on clinical management in 2017. Clinics and Research in Hepatology and Gastroenterology 41:6, pages 617-625.
Crossref
Crossref
Cumali Efe, Hannes Hagström, Henriette Ytting, Rahima A. Bhanji, Niklas F. Müller, Qixia Wang, Tugrul Purnak, Luigi Muratori, Mårten Werner, Hanns-Ulrich Marschall, Paolo Muratori, Fulya Gunşar, Daniel Klintman, Albert Parés, Alexandra Heurgué–Berlot, Thomas D. Schiano, Mustafa Cengiz, Michele May-Sien Tana, Xiong Ma, Aldo J. Montano-Loza, Thomas Berg, Sumita Verma, Fin Stolze Larsen, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida & Staffan Wahlin. (2017) Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 15:12, pages 1950-1956.e1.
Crossref
Crossref
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani & Diego Vergani. (2017) Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 23:33, pages 6030-6048.
Crossref
Crossref
Xin Zhao, MingJiang Liu, JinGui Li, ShaoJie Yin, YangYang Wu & AnYuan Wang. (2017) Antimalarial agent artesunate protects Concanavalin A-induced autoimmune hepatitis in mice by inhibiting inflammatory responses. Chemico-Biological Interactions 274, pages 116-123.
Crossref
Crossref
Angela Cropley & Martin Weltman. (2017) The use of immunosuppression in autoimmune hepatitis: A current literature review. Clinical and Molecular Hepatology 23:1, pages 22-26.
Crossref
Crossref
D. Vergani & G. Mieli-Vergani. 2017. The Digestive Involvement in Systemic Autoimmune Diseases. The Digestive Involvement in Systemic Autoimmune Diseases
103
117
.
Rodrigo Liberal, Edward L. Krawitt, John M. Vierling, Michael P. Manns, Giorgina Mieli-Vergani & Diego Vergani. (2016) Cutting edge issues in autoimmune hepatitis. Journal of Autoimmunity 75, pages 6-19.
Crossref
Crossref
Paolo Muratori, Claudine Lalanne, Giampaolo Bianchi, Marco Lenzi & Luigi Muratori. (2016) Predictive factors of poor response to therapy in Autoimmune Hepatitis. Digestive and Liver Disease 48:9, pages 1078-1081.
Crossref
Crossref
Ranran Han, Juan Gao, Hui Zhai, Jinting Xiao, Ya'nan Ding & Junwei Hao. (2016) RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages. Experimental Neurology 280, pages 106-114.
Crossref
Crossref
Craig Lammert, Veronica M. Loy, Kiyoko Oshima & Samer Gawrieh. (2016) Management of Difficult Cases of Autoimmune Hepatitis. Current Gastroenterology Reports 18:2.
Crossref
Crossref
Nwe Ni Than, Hannah C. Jeffery & Ye H. Oo. (2016) Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-12.
Crossref
Crossref
. (2015) Everolimus. Reactions Weekly 1582:1, pages 198-198.
Crossref
Crossref
John M. Vierling. (2015) Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2088-2108.
Crossref
Crossref